Skip to main content

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Investor Investigation Over Possible Violations of Federal Securities Laws

  • If you purchased shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

August 8, 2014 (Shareholders Foundation) - An investigation on behalf of investors of Regeneron Pharmaceuticals Inc (NASDAQ:REGN shares over potential securities laws violations by Regeneron Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchase...



You must register (for free) or login to view the entire investigation.